Results 251 to 260 of about 156,351 (339)

Neurological manifestations in Pakistani lysosomal storage disorders patients and molecular characterization of Gaucher disease

, 2021
Rutaba Gul, Sabika Firasat, Mulazim Hussain, Muhammad Tufail, Waheed Ahmad, Kiran Afshan   +5 more
openalex   +2 more sources

Calcium retinoate nanoparticle mediated microglial polarization to regulate inflammatory microenvironment for therapy of neuroinflammatory disease

BMEMat, EarlyView.
A nano‐drug based on retinoic acid and calcium is developed, which can be rapily endocytosed by microglia and decomposed into small molecule/ion storms in lysosomes. This nano‐drug regulates microglial phenotype switching from M1 to M2 while indirectly guiding neuronal differentiation of endogenous neural stem cells, thereby ameliorating ...
Shuo Zhang, Yuan Yao, Wenfeng Shao, Jiapei Shi, Benjie Wei, Chunhui Sun, Jingang Wang, Jiaming Shi, Nik Ahmad Nizam Nik Malek, Wan Hairul Anuar Kamaruddin, Na Ren, Yuchun Tang, Wenjuan Zhou, Shuping Wang   +13 more
wiley   +1 more source

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases [PDF]

, 2006
Stephan D. Gadola, Jonathan D. Silk, Aruna Jeans, Petr A. Illarionov, Mariolina Salio, Gurdyal S. Besra, Raymond A. Dwek, Terry D. Butters, Frances M. Platt, Vincenzo Cerundolo   +9 more
openalex   +1 more source

Advancing design strategies in smart stimulus‐responsive liposomes for drug release and nanomedicine

BMEMat, EarlyView.
Schematic illustration of stimulus‐responsive liposomes designed for controlled drug release and nanomedicine. The innermost circle represents different liposomal structures, including unilamellar, multilamellar, and multivesicular liposomes. The middle layer illustrates the responsive phospholipid components.
Yuchen Guo, Nan Li, Daiwei Zhang, Jingya Gu, Zhihuan Liao, Zihao Teng, Xiangfu Du, Peter S. Timashev, Shipeng Chen, Shuaidong Huo   +9 more
wiley   +1 more source

Reply—Nonimmune Hydrops Fetalis and Lysosomal Storage Diseases

Pediatrics and Neonatology, 2013
Ozge Surmeli-Onay, Ayse Korkmaz
doaj   +1 more source

The emerging role and clinicopathological significance of MFSD12 in cancer and lysosomal storage diseases. [PDF]

Front Pharmacol
Ding L.
europepmc   +1 more source

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

Health care costs of home care enzyme replacement therapy for patients with lysosomal storage diseases in Germany. [PDF]

Orphanet J Rare Dis
Heinrich R, Claus F, Schoenfelder T.
europepmc   +1 more source

Polysaccharide storage myopathy - the story so far [PDF]

, 2015
Annandale, Annandale, Arad, Baird, Borgia, Borgia, Byrne, De La Corte, De La Corte, De La Corte, DiMauro, Firshman, Firshman, Firshman, Herszberg, Hunt, Johlig, Lacombe, Larcher, Ledwith, Lentz, McCoy, McCue, McCue, McCue, McCue, McCue, McCue, Naylor, Naylor, Quiroz-Rothe, Ribeiro, Schwarz, Sierra, Soliman, Stanley, Stanley, Valberg, Valberg, Valberg, Valberg, Valberg, Valentine, Valentine, Valentine, Valentine   +45 more
core   +2 more sources

Lysosomal storage diseases: The topical problem of pediatrics and the current possibilities of pathogenetic treatment

, 2016
П. В. Новиков
openalex   +1 more source